ByteDance Secures $29.6 Billion Loan to Boost AI Investment 
Fast Retailing Shares Drop as Uniqlo Japan August Sales Fall 
CATL Shares Fall as Hungary Plant Faces Safety Halt 
South Korea, US Discuss Chip Investments Amid Tariff Plans 
US Tech Giants’ AI Bond Boom Raises Euro Zone Borrowing Risks 
BP Names Ian Tyler Permanent Chairman After Governance Shake-Up 
Volkswagen Approves 50,000 More Job Cuts in Major Restructuring 
Tesla Cybercab Rides Launch in Austin as NHTSA Reviews Rollout 
Qantas Near-Miss Raises Sydney Air Traffic Controller Fatigue Concerns 
Shein Shares Drop 5% After Weak Hong Kong IPO Debut 
Deutsche Telekom Shares Rise as Elliott Pushes Against T-Mobile Merger 
OpenAI Rejects Apple Trade Secret Theft Claims 
Berkshire Hathaway Eyes Bigger Stakes in Japan’s Top Trading Houses 
OpenAI Nears Astra AI Model Launch With Safety Focus 
Microsoft to Reveal Azure Revenue in Major Reporting Shake-Up 
Tesla Cybercab Launch Puts Robotaxi Ambitions in Focus 
Honda Targets $9.4 Billion in Cost Cuts as China EV Competition Intensifies 
Add as a preferred source on Google
BURLINGTON, Mass., March 07, 2018 -- Flexion Therapeutics, Inc. (Nasdaq:FLXN) will be presenting at the Cowen 38th Annual Health Care Conference in Boston, Massachusetts. Michael Clayman, M.D., President and Chief Executive Officer, is scheduled to present at 10:40 a.m. Eastern Time on Wednesday, March 14, 2018. To access the live webcast and subsequent archived recording of the presentation, visit the Flexion website at http://ir.flexiontherapeutics.com.
About Flexion Therapeutics
Flexion Therapeutics (Nasdaq:FLXN) is a biopharmaceutical company focused on the development and commercialization of novel, local therapies for the treatment of patients with musculoskeletal conditions, beginning with osteoarthritis, a type of degenerative arthritis. The company's core values are focus, ingenuity, tenacity, transparency and fun. Flexion was named one of The Boston Business Journal's 2017 Best Places to Work and one of the Top Places to Work in Massachusetts by The Boston Globe.
Contact:
Scott Young
Vice President, Corporate Communications and Investor Relations
Flexion Therapeutics, Inc.
T: 781-305-7194
[email protected]
